Pharmaceuticals

Novo Nordisk to invest $4.1 billion to expand U.S. manufacturing capacity

bexib
By bexib 0 Min Read

The investment is expected to fund a new fill-finish manufacturing facility to ramp up production of injectable treatments for obesity and chronic diseases.

You Might Also Like

The CMT Research Foundation will fund research projects to develop treatments for CMT.

National Policy Institute releases report detailing the importance of Medicare Advantage in employee group exemption plans

Leveraging biomarkers to develop innovative antibody-drug conjugates for the treatment of advanced solid tumors

Drug Recall: Q&A with Beth Riggio

International KCL research project aims to develop smart drugs for malignant cancer

Share This Article
Previous Article 22 Free SEO tools to empower your growth strategy
Next Article Ethereum Foundation Hacked: Here’s What Happened – Investorempires.com
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

New e -commerce tool: January 30, 2025
Retail & E-commerce
Promote the economic collaboration for 2025 business tournaments in Italy and India
Manufacturing
How to create print on demand products
Retail & E-commerce
Is this episode a deep fake? -What is a brewing podcast (episode 9)
Insurance